{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:39:27Z","timestamp":1776944367997,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014034","name":"Foundation for Research in Rheumatology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014034","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pancretan Health Association"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.berh.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T16:50:09Z","timestamp":1563814209000},"page":"101425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Suspected systemic rheumatic diseases in patients presenting with cytopenias"],"prefix":"10.1016","volume":"33","author":[{"given":"Dionysis","family":"Nikolopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Adamichou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bertsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2019.06.007_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/art.40674","article-title":"Brief report: how do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new classification criteria","volume":"71","author":"Mosca","year":"2019","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3109\/10428194.2013.821703","article-title":"New onset pancytopenia in adults: a review of underlying pathologies and their associated clinical and laboratory findings","volume":"55","author":"Devitt","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.berh.2019.06.007_bib3","doi-asserted-by":"crossref","first-page":"g1721","DOI":"10.1136\/bmj.g1721","article-title":"Investigating an incidental finding of lymphopenia","volume":"348","author":"Brass","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2019.06.007_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/asheducation.V2012.1.485.3798522","article-title":"Low blood counts: immune mediated, idiopathic, or myelodysplasia","volume":"2012","author":"Valent","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.berh.2019.06.007_bib5","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2005-07-3046","article-title":"The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?","volume":"107","author":"Beutler","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.berh.2019.06.007_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","article-title":"Relationship between platelet count and bleeding risk in thrombocytopenic patients","volume":"18","author":"Slichter","year":"2004","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.berh.2019.06.007_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/096120399678847704","article-title":"Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture","volume":"8","author":"Alarcon","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2019.06.007_bib8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.24020","article-title":"Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort","volume":"59","author":"Duran","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.22376","article-title":"Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor","volume":"56","author":"Fernandez","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0961203308090990","article-title":"Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective","volume":"17","author":"Jeffries","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2019.06.007_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/09537101003735564","article-title":"Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis","volume":"21","author":"Zhao","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.berh.2019.06.007_bib12","first-page":"926","article-title":"Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies","volume":"16","author":"Deleze","year":"1989","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9343(99)00413-1","article-title":"Autoimmune hemolytic anemia in patients with systemic lupus erythematosus","volume":"108","author":"Kokori","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2019.06.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000104742.42401.e2","article-title":"The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among \u201cHispanics\u201d","volume":"83","author":"Pons-Estel","year":"2004","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.06.007_bib15","first-page":"319","article-title":"SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up","volume":"74","author":"Worrall","year":"1990","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.berh.2019.06.007_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.semarthrit.2015.11.003","article-title":"Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: data from a multiethnic Latin American cohort","volume":"45","author":"Gonzalez-Naranjo","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/rheumatology\/keh048","article-title":"Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations","volume":"43","author":"Vila","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2019.06.007_bib18","first-page":"605","article-title":"Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus","volume":"80","author":"Nossent","year":"1991","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.berh.2019.06.007_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/art.22224","article-title":"Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual","volume":"55","author":"Vila","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.autrev.2013.02.001","article-title":"Management of immune cytopenias in patients with systemic lupus erythematosus - old and new","volume":"12","author":"Newman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2019.06.007_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-200207000-00004","article-title":"Primary Sjogren syndrome: hematologic patterns of disease expression","volume":"81","author":"Ramos-Casals","year":"2002","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.06.007_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10067-009-1366-x","article-title":"Clinical analysis of primary Sjogren's syndrome complicating anemia","volume":"29","author":"Zhou","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.06.007_bib24","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s10067-015-3081-0","article-title":"Clinical and serologic features of primary Sjogren's syndrome concomitant with autoimmune hemolytic anemia: a large-scale cross-sectional study","volume":"34","author":"Wen","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.62.5.476","article-title":"Primary Sjogren's syndrome associated agranulocytosis: a benign disorder?","volume":"62","author":"Coppo","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.06.007_bib26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/rheumatology\/40.8.948","article-title":"Autoimmune neutropenia, thrombocytopenia and Coombs positivity in a patient with primary Sjogren's syndrome","volume":"40","author":"Klepfish","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2019.06.007_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005565","article-title":"Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: a retrospective study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.06.007_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012989","article-title":"Relapsed\/refractory acquired thrombotic thrombocytopenic purpura in a patient with Sjogren syndrome: case report and review of the literature","volume":"97","author":"Sun","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.06.007_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1874312901408010129","article-title":"Felty's syndrome, insights and updates","volume":"8","author":"Owlia","year":"2014","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.berh.2019.06.007_bib30","first-page":"1163","article-title":"The clinical course of Felty's syndrome compared to matched controls","volume":"18","author":"Sibley","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.semarthrit.2014.12.001","article-title":"Scleroderma renal crisis","volume":"44","author":"Bose","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.berh.2019.06.007_bib33","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/acr.22872","article-title":"Epidemiology of mixed connective tissue disease, 1985\u20132014: a population-based study","volume":"68","author":"Ungprasert","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2019.06.007_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11926-014-0494-8","article-title":"The significance and management of thrombocytopenia in antiphospholipid syndrome","volume":"17","author":"Artim-Esen","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2019.06.007_bib35","first-page":"9","article-title":"Catastrophic antiphospholipid syndrome: a clinical review","volume":"3","author":"Nayer","year":"2014","journal-title":"J\u00a0Nephropathol"},{"key":"10.1016\/j.berh.2019.06.007_bib36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2019.06.007_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.06.007_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still's disease","volume":"33","author":"Efthimiou","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a75007e1-492a-4bcb-80a8-28b4d432c099","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2019.06.007_bib40","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bjophthalmol-2015-307455","article-title":"Lymphopenia as a predictor of sarcoidosis in patients with uveitis","volume":"100","author":"Jones","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2019.06.007_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MD.0b013e31822618b3","article-title":"Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients","volume":"90","author":"Mahevas","year":"2011","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.06.007_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.berh.2019.06.007_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fendo.2017.00138","article-title":"Systemic lupus erythematosus and thyroid autoimmunity","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.berh.2019.06.007_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1741-7015-11-73","article-title":"How do autoimmune diseases cluster in families? A systematic review and meta-analysis","volume":"11","author":"Cardenas-Roldan","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.berh.2019.06.007_bib45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/acr.23292","article-title":"Performance of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data","volume":"70","author":"Leuchten","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2019.06.007_bib46","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.3399\/bjgp14X681601","article-title":"A\u00a0clinical overview of autoantibodies in general practice rheumatology","volume":"64","author":"Lee","year":"2014","journal-title":"Br J Gen Pract"},{"issue":"7","key":"10.1016\/j.berh.2019.06.007_bib47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/acr.23712","article-title":"Antinuclear antibody-negative systemic lupus erythematosus in an International inception cohort","volume":"71","author":"Choi","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2019.06.007_bib48","article-title":"Increased sensitivity of the new (2017) and the 2012 SLICC as compared to the Acr 1997 classification criteria in early systemic lupus erythematosus (SLE): the 2017 and 2012 criteria may classify non-overlapping subgroups of patients [abstract]","volume":"70","author":"Adamichou","year":"2018","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib49","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib50","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3899\/jrheum.161465","article-title":"Cryoglobulinemia in Sjogren syndrome: a disease subset that links higher systemic disease activity, autoimmunity, and local B cell proliferation in mucosa-associated lymphoid tissue","volume":"44","author":"Quartuccio","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3343\/alm.2013.33.1.1","article-title":"Purpose and criteria for blood smear scan, blood smear examination, and blood smear review","volume":"33","author":"Gulati","year":"2013","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.berh.2019.06.007_bib52","first-page":"76","article-title":"Indications for bone marrow examination in autoimmune disorders with concurrent haematologic alterations","volume":"31","author":"Papageorgiou","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/ard.2005.041673","article-title":"Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment","volume":"65","author":"Giannouli","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.06.007_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ejh.12320","article-title":"Bone marrow examination in patients with immune thrombocytopenia: is there anything different in older patients?","volume":"93","author":"Gunduz","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.berh.2019.06.007_bib55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01451051","article-title":"Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias","volume":"17","author":"Pereira","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/00313029109061430","article-title":"Bone marrow findings in lupus patients with pancytopenia","volume":"23","author":"Feng","year":"1991","journal-title":"Pathology"},{"key":"10.1016\/j.berh.2019.06.007_bib57","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ajh.20593","article-title":"Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study","volume":"81","author":"Voulgarelis","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.berh.2019.06.007_bib58","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00296-014-3162-4","article-title":"Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review","volume":"35","author":"Chalayer","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2019.06.007_bib59","first-page":"58","article-title":"Systemic lupus erythematosus and myelofibrosis: a case report and revision of literature","volume":"9","author":"Del Porto","year":"2018","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.berh.2019.06.007_bib60","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nrrheum.2013.103","article-title":"Diagnostic criteria for systemic lupus erythematosus: has the time come?","volume":"9","author":"Bertsias","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib61","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib62","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/annrheumdis-2018-214685","article-title":"Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus","volume":"78","author":"Tedeschi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.06.007_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203313512883","article-title":"The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus in two multiethnic cohorts: a commentary","volume":"23","author":"Pons-Estel","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2019.06.007_bib64","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/acr.22539","article-title":"Classification of systemic lupus erythematosus: systemic lupus international collaborating clinics versus American college of rheumatology criteria. A comparative study of 2,055 patients from a real-life, international systemic lupus erythematosus cohort","volume":"67","author":"Ines","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2019.06.007_bib65","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/0961203316665710","article-title":"Factors associated with disease expression patterns in systemic lupus erythematosus patients: results from LUMINA (LXXVII), a multiethnic US cohort","volume":"26","author":"Ugarte-Gil","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2019.06.007_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000475493","article-title":"Renal-limited \u201cLupus-Like\u201d nephritis: how much of a lupus?","volume":"7","author":"Maziad","year":"2017","journal-title":"Case Rep Nephrol Dial"},{"key":"10.1016\/j.berh.2019.06.007_bib67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American college of rheumatology\/European League against rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.06.007_bib68","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.06.007_bib69","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrrheum.2017.124","article-title":"Diagnosing antiphospholipid syndrome: \u2018extra-criteria\u2019 manifestations and technical advances","volume":"13","author":"Sciascia","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.06.007_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2141.1997.d01-1982.x","article-title":"Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period","volume":"96","author":"Savage","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.berh.2019.06.007_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.berh.2019.06.007_bib72","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00002018-200326100-00003","article-title":"Drug-induced myelosuppression : diagnosis and management","volume":"26","author":"Carey","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.berh.2019.06.007_bib73","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOH.0b013e3282fa7470","article-title":"Aplastic anemia","volume":"15","author":"Young","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.berh.2019.06.007_bib74","first-page":"98","article-title":"Drug-induced immune hemolytic anemia","volume":"8","author":"Garratty","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.berh.2019.06.007_bib75","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.1994.03510360061038","article-title":"Agranulocytosis","volume":"271","author":"Young","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.berh.2019.06.007_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000034","article-title":"Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry","volume":"1","author":"Salmon","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2019.06.007_bib77","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/asheducation-2009.1.153","article-title":"Drug-induced thrombocytopenia: pathogenesis, evaluation, and management","author":"George","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.berh.2019.06.007_bib78","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2019.06.007_bib79","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fimmu.2016.00364","article-title":"Impact of viral infections on hematopoiesis: from beneficial to detrimental effects on bone marrow output","volume":"7","author":"Pascutti","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2019.06.007_bib80","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2019.06.007_bib81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1398.018","article-title":"Two-step mechanism of virus-induced autoimmune hemolytic anemia","volume":"1109","author":"Coutelier","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.berh.2019.06.007_bib82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jama.2018.19498","article-title":"Malar rash and polyarthritis","volume":"321","author":"Chatterjee","year":"2019","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.berh.2019.06.007_bib83","doi-asserted-by":"crossref","first-page":"e1088","DOI":"10.1016\/j.ijid.2010.08.002","article-title":"Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas","volume":"14","author":"Firnhaber","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.berh.2019.06.007_bib84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.berh.2019.06.007_bib85","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2019.06.007_bib86","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes","volume":"361","author":"Tefferi","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2019.06.007_bib87","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2362.2004.01417.x","article-title":"Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts","volume":"34","author":"Voulgarelis","year":"2004","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.berh.2019.06.007_bib88","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000446062","article-title":"Autoimmunity and inflammation in myelodysplastic syndromes","volume":"136","author":"Wolach","year":"2016","journal-title":"Acta Haematol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219300944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219300944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:19:47Z","timestamp":1761499187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694219300944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1521694219300944"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2019.06.007","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suspected systemic rheumatic diseases in patients presenting with cytopenias","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101425"}}